On November 9, 2012, the Board of Directors of TG Therapeutics, Inc. appointed Yann Echelard to the Board pursuant to that certain common stock purchase agreement, dated as of January 30, 2012, as amended on May 11, May 21 and June 4, 2012, by and between the company and LFB. Dr. Echelard will serve as a director until his term expires at the 2013 annual meeting of stockholders, at which time he will stand for reelection by the company's stockholders. The company has not yet appointed Mr. Echelard to any Board committees.